April 04, 2011 -- Finansinspektionen (the Swedish Financial Supervisory Authority) approved on April 4 Genovis prospectus for a new share issue with preference for existing shareholders, the subscription period is April 13 – May 6 2011. Starting Tuesday the 5 of April the prospectus will be available in Swedish on Genovis and Finansinspektionens home page.
Genovis AB (publ)
The board of directors
For more information, please contact: Sarah Fredriksson, CEO, Genovis AB Tel: 46 46 10 12 35 sarah.fredriksson@genovis.com
Genovis develops and designs smart nanoparticles for preclinical imaging and diagnostics and also develops and sells tools for modification of antibodies.Genovis shares are listed on Nasdaq OMX First North and Thenberg & Kinde Fondkommission ( 46 (0)31 745 50 00) is the Company’s certified adviser.
